Literature DB >> 31552496

Microbiota: a novel regulator of pain.

Manon Defaye1, Sandie Gervason2,3, Christophe Altier1, Jean-Yves Berthon2, Denis Ardid3, Edith Filaire2,4, Frédéric Antonio Carvalho5.   

Abstract

Among the various regulators of the nervous system, the gut microbiota has been recently described to have the potential to modulate neuronal cells activation. While bacteria-derived products can induce aversive responses and influence pain perception, recent work suggests that "abnormal" microbiota is associated with neurological diseases such as Alzheimer's, Parkinson's disease or autism spectrum disorder (ASD). Here we review how the gut microbiota modulates afferent sensory neurons function and pain, highlighting the role of the microbiota/gut/brain axis in the control of behaviors and neurological diseases. We outline the changes in gut microbiota, known as dysbiosis, and their influence on painful gastrointestinal disorders. Furthermore, both direct host/microbiota interaction that implicates activation of "pain-sensing" neurons by metabolites, or indirect communication via immune activation is discussed. Finally, treatment options targeting the gut microbiota, including pre- or probiotics, will be proposed. Further studies on microbiota/nervous system interaction should lead to the identification of novel microbial ligands and host receptor-targeted drugs, which could ultimately improve chronic pain management and well-being.

Entities:  

Keywords:  Microbiota; Microbiota/gut/brain axis; Probiotic treatment; Visceral pain

Mesh:

Year:  2019        PMID: 31552496     DOI: 10.1007/s00702-019-02083-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  231 in total

1.  A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats.

Authors:  S Agostini; M Goubern; V Tondereau; C Salvador-Cartier; V Bezirard; M Lévèque; H Keränen; V Theodorou; S Bourdu-Naturel; N Goupil-Feuillerat; S Legrain-Raspaud; H Eutamene
Journal:  Neurogastroenterol Motil       Date:  2012-01-25       Impact factor: 3.598

2.  Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats.

Authors:  T Kamiya; L Wang; P Forsythe; G Goettsche; Y Mao; Y Wang; G Tougas; J Bienenstock
Journal:  Gut       Date:  2005-12-16       Impact factor: 23.059

3.  Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia.

Authors:  M K Nøhr; K L Egerod; S H Christiansen; A Gille; S Offermanns; T W Schwartz; M Møller
Journal:  Neuroscience       Date:  2015-01-28       Impact factor: 3.590

Review 4.  Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.

Authors:  Marta Seretny; Gillian L Currie; Emily S Sena; Sabrina Ramnarine; Robin Grant; Malcolm R MacLeod; Leslie A Colvin; Marie Fallon
Journal:  Pain       Date:  2014-09-23       Impact factor: 6.961

Review 5.  Probiotics for the Management of Infantile Colic.

Authors:  Hania Szajewska; Radosław Dryl
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-07       Impact factor: 2.839

6.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.

Authors:  Hubert Plovier; Amandine Everard; Céline Druart; Clara Depommier; Matthias Van Hul; Lucie Geurts; Julien Chilloux; Noora Ottman; Thibaut Duparc; Laeticia Lichtenstein; Antonis Myridakis; Nathalie M Delzenne; Judith Klievink; Arnab Bhattacharjee; Kees C H van der Ark; Steven Aalvink; Laurent O Martinez; Marc-Emmanuel Dumas; Dominique Maiter; Audrey Loumaye; Michel P Hermans; Jean-Paul Thissen; Clara Belzer; Willem M de Vos; Patrice D Cani
Journal:  Nat Med       Date:  2016-11-28       Impact factor: 53.440

Review 7.  Peptidoglycan recognition by the innate immune system.

Authors:  Andrea J Wolf; David M Underhill
Journal:  Nat Rev Immunol       Date:  2018-01-02       Impact factor: 53.106

8.  Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease.

Authors:  Giovanni Barbara; Eleonora Scaioli; Maria Raffaella Barbaro; Elena Biagi; Luca Laghi; Cesare Cremon; Giovanni Marasco; Antonio Colecchia; Gianfranco Picone; Nunzio Salfi; Francesco Capozzi; Patrizia Brigidi; Davide Festi
Journal:  Gut       Date:  2016-09-12       Impact factor: 23.059

9.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.

Authors:  Martin Baumgart; Belgin Dogan; Mark Rishniw; Gil Weitzman; Brian Bosworth; Rhonda Yantiss; Renato H Orsi; Martin Wiedmann; Patrick McDonough; Sung Guk Kim; Douglas Berg; Ynte Schukken; Ellen Scherl; Kenneth W Simpson
Journal:  ISME J       Date:  2007-07-12       Impact factor: 10.302

10.  Fungal microbiota dysbiosis in IBD.

Authors:  Harry Sokol; Valentin Leducq; Hugues Aschard; Hang-Phuong Pham; Sarah Jegou; Cecilia Landman; David Cohen; Giuseppina Liguori; Anne Bourrier; Isabelle Nion-Larmurier; Jacques Cosnes; Philippe Seksik; Philippe Langella; David Skurnik; Mathias L Richard; Laurent Beaugerie
Journal:  Gut       Date:  2016-02-03       Impact factor: 23.059

View more
  18 in total

1.  Advances in the understanding and treatment of pain and headache.

Authors:  Radhouane Dallel
Journal:  J Neural Transm (Vienna)       Date:  2020-04       Impact factor: 3.575

2.  Dietary supplementation of gingerols- and shogaols-enriched ginger root extract attenuate pain-associated behaviors while modulating gut microbiota and metabolites in rats with spinal nerve ligation.

Authors:  Chwan-Li Shen; Rui Wang; Guangchen Ji; Moamen M Elmassry; Masoud Zabet-Moghaddam; Heather Vellers; Abdul N Hamood; Xiaoxia Gong; Parvin Mirzaei; Shengmin Sang; Volker Neugebauer
Journal:  J Nutr Biochem       Date:  2021-11-06       Impact factor: 6.048

Review 3.  Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis.

Authors:  Daria Augustyniak; Eliza Kramarska; Paweł Mackiewicz; Magdalena Orczyk-Pawiłowicz; Fionnuala T Lundy
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 4.  Mechanisms of microbial-neuronal interactions in pain and nociception.

Authors:  Valentina N Lagomarsino; Aleksandar D Kostic; Isaac M Chiu
Journal:  Neurobiol Pain       Date:  2020-12-11

5.  Evaluation of Gut Microbiota in Patients With Vulvovestibular Syndrome.

Authors:  Laura Coda; Paola Cassis; Stefania Angioletti; Cristina Angeloni; Stefania Piloni; Cristian Testa
Journal:  J Clin Med Res       Date:  2021-02-25

Review 6.  Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease.

Authors:  Davide Banfi; Elisabetta Moro; Annalisa Bosi; Michela Bistoletti; Silvia Cerantola; Francesca Crema; Fabrizio Maggi; Maria Cecilia Giron; Cristina Giaroni; Andreina Baj
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

Review 7.  Gut Microbiota and Complications of Type-2 Diabetes.

Authors:  Camelia Oana Iatcu; Aimee Steen; Mihai Covasa
Journal:  Nutrients       Date:  2021-12-30       Impact factor: 5.717

Review 8.  Animal models of visceral pain and the role of the microbiome.

Authors:  Christine West; Karen-Anne McVey Neufeld
Journal:  Neurobiol Pain       Date:  2021-05-28

9.  A role for gut microbiota in early-life stress-induced widespread muscle pain in the adult rat.

Authors:  Paul G Green; Pedro Alvarez; Jon D Levine
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

Review 10.  Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.

Authors:  Kinga Sałat
Journal:  Pharmacol Rep       Date:  2020-04-28       Impact factor: 3.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.